<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04209894</url>
  </required_header>
  <id_info>
    <org_study_id>karamanlioglu.duygu</org_study_id>
    <nct_id>NCT04209894</nct_id>
  </id_info>
  <brief_title>A Clinical Study of Sub-clinical Enthesitis in Patients With Psoriasis and Healthy Controls</brief_title>
  <official_title>Subclinical Enthesitis in Psoriasis Patients Without Musculoskeletal Complaints and Healthy Controls by Ultrasonography and Incidence of Enthesitis Development During 6 Months</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fatih Sultan Mehmet Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fatih Sultan Mehmet Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A clinical study of subclinical enthesitis in patients with psoriasis and healthy controls
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 30 patients with psoriasis and 30 age-matched healthy controls, all without
      musculoskeletal diseases, will be recruited. They will undergo dermatological assessment and
      a blinded ultrasound (US) evaluation. Clinical assessment included demographics, severity of
      psoriasis and musculoskeletal clinical examination. Evaluation consisted of the detection of
      grey scale (GS) enthesitis and Power Doppler signal in enthesis areas. The Madrid Sonography
      Enthesitis Index (MASEI) scoring system was used to quantify the extent of sonographic
      entheseal abnormalities.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 15, 2020</start_date>
  <completion_date type="Anticipated">December 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Subclinical Enthesitis in psoriasis patients without musculoskeletal complaints and healthy controls by ultrasonography and incidence of enthesitis development during 6 months</measure>
    <time_frame>6 months.</time_frame>
    <description>Incidence of subclinical enthesitis To investigate the incidence of subclinical enthesitis in patients with psoriasis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with Risk factors of subclinical enthesitis</measure>
    <time_frame>6 months</time_frame>
    <description>To find out predictor factors of subclinical enthesitis in patients with psoriasis</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Enthesitis</condition>
  <arm_group>
    <arm_group_label>Psoriasis</arm_group_label>
    <description>They will undergo dermatological assessment and a blinded ultrasound (US) evaluation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>They will also undergo dermatological assessment and a blinded ultrasound (US) evaluation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>Evaluation consisted of the detection of grey scale (GS) enthesitis and Power Doppler signal in enthesis areas of participants. The Madrid Sonography Enthesitis Index (MASEI) scoring system was used to quantify the extent of sonographic entheseal abnormalities</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Psoriasis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Both patients with psoriasis and healthy controls.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age≥18years

          -  Patients with psoriasis without musculoskeletal symptoms

          -  Healthy controls

          -  No joint involvement and no clinical symptoms and signs of enthesitis and synovitis

        Exclusion Criteria:

          -  Have history of gout or arthritis or peripheral neurological disease of lower
             extremity.

          -  Have history of trauma and intensive sport activity in last 2 weeks.

          -  Have received any systemic therapy (i.e. DMARD, NSAIDs, corticosteroids,
             immunosuppressants, retinoids or biological agents) in 3 months

          -  Pregnant or breast-feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Duygu Silte Karamanlioglu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fatih Sultan Mehmet Training and Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Feyza Unlu Ozkan, Assoc. Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Fatih Sultan Mehmet Training and Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eylem Ceren Arikan, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Fatih Sultan Mehmet Training and Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gulcan Ozturk, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Fatih Sultan Mehmet Training and Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>İlknur Aktas, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Fatih Sultan Mehmet Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fatih Sultan Mehmet Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <state>Atasehir</state>
        <zip>34758</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 14, 2019</study_first_submitted>
  <study_first_submitted_qc>December 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2019</study_first_posted>
  <last_update_submitted>February 23, 2020</last_update_submitted>
  <last_update_submitted_qc>February 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fatih Sultan Mehmet Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Duygu Karamanlıoğlu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>enthesitis</keyword>
  <keyword>psoriasis</keyword>
  <keyword>ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enthesopathy</mesh_term>
    <mesh_term>Psoriasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

